Javascript must be enabled to continue!
Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
View through CrossRef
Abstract
Background
The efficacy and safety of artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DP) against asexual parasites population has been documented. However, the effect of these anti-malarials on sexual parasites is still less clear. Gametocyte clearance following treatment is essential for malaria control and elimination efforts; therefore, the study sought to determine trends in gametocyte clearance after AL or DP treatment in children from a malaria-endemic site in Kenya.
Methods
Children aged between 0.5 and 12 years from Busia, western Kenya with uncomplicated Plasmodium falciparum malaria were assigned randomly to AL or DP treatment. A total of 334 children were enrolled, and dried blood spot samples were collected for up to 6 weeks after treatment during the peak malaria transmission season in 2016 and preserved. Plasmodium falciparum gametocytes were detected by qRT-PCR and gametocyte prevalence, density and mean duration of gametocyte carriage were determined.
Results
At baseline, all the 334 children had positive asexual parasites by microscopy, 12% (40/334) had detectable gametocyte by microscopy, and 83.7% (253/302) children had gametocytes by RT-qPCR. Gametocyte prevalence by RT-qPCR decreased from 85.1% (126/148) at day 0 to 7.04% (5/71) at day 42 in AL group and from 82.4% (127/154) at day 0 to 14.5% (11/74) at day 42 in DP group. The average duration of gametocyte carriage as estimated by qRT-PCR was slightly shorter in the AL group (4.5 days) than in the DP group (5.1 days) but not significantly different (p = 0.301).
Conclusion
The study identifies no significant difference between AL and DP in gametocyte clearance. Gametocytes persisted up to 42 days post treatment in minority of individuals in both treatment arms. A gametocytocidal drug, in combination with artemisinin-based combination therapy, will be useful in blocking malaria transmission more efficiently.
Springer Science and Business Media LLC
Title: Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
Description:
Abstract
Background
The efficacy and safety of artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DP) against asexual parasites population has been documented.
However, the effect of these anti-malarials on sexual parasites is still less clear.
Gametocyte clearance following treatment is essential for malaria control and elimination efforts; therefore, the study sought to determine trends in gametocyte clearance after AL or DP treatment in children from a malaria-endemic site in Kenya.
Methods
Children aged between 0.
5 and 12 years from Busia, western Kenya with uncomplicated Plasmodium falciparum malaria were assigned randomly to AL or DP treatment.
A total of 334 children were enrolled, and dried blood spot samples were collected for up to 6 weeks after treatment during the peak malaria transmission season in 2016 and preserved.
Plasmodium falciparum gametocytes were detected by qRT-PCR and gametocyte prevalence, density and mean duration of gametocyte carriage were determined.
Results
At baseline, all the 334 children had positive asexual parasites by microscopy, 12% (40/334) had detectable gametocyte by microscopy, and 83.
7% (253/302) children had gametocytes by RT-qPCR.
Gametocyte prevalence by RT-qPCR decreased from 85.
1% (126/148) at day 0 to 7.
04% (5/71) at day 42 in AL group and from 82.
4% (127/154) at day 0 to 14.
5% (11/74) at day 42 in DP group.
The average duration of gametocyte carriage as estimated by qRT-PCR was slightly shorter in the AL group (4.
5 days) than in the DP group (5.
1 days) but not significantly different (p = 0.
301).
Conclusion
The study identifies no significant difference between AL and DP in gametocyte clearance.
Gametocytes persisted up to 42 days post treatment in minority of individuals in both treatment arms.
A gametocytocidal drug, in combination with artemisinin-based combination therapy, will be useful in blocking malaria transmission more efficiently.
Related Results
Population pharmacokinetics of artemether–lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria
Population pharmacokinetics of artemether–lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria
AimsResistance to the artemisinins and the artemisinin‐based combination therapy (ACT) partner drugs has developed in Southeast Asia, and artemisinin resistance has also emerged in...
Efficacy of dihydroartemisinin/piperaquine and artesunate monotherapy for the treatment of uncomplicated Plasmodium falciparum malaria in Central Vietnam
Efficacy of dihydroartemisinin/piperaquine and artesunate monotherapy for the treatment of uncomplicated Plasmodium falciparum malaria in Central Vietnam
Abstract
Background
Artemisinin-based combination therapies (ACTs) have significantly contributed to reduce Plasmodium falciparu...
Selection of pfcrt K76 and pfmdr1 N86 Coding Alleles after Uncomplicated Malaria Treatment by Artemether-Lumefantrine in Mali
Selection of pfcrt K76 and pfmdr1 N86 Coding Alleles after Uncomplicated Malaria Treatment by Artemether-Lumefantrine in Mali
Background: Artemether-lumefantrine is a highly effective artemisinin-based combination therapy that was adopted in Mali as first-line treatment for uncomplicated Plasmodium falcip...
Efficacy and tolerability of artemether–lumefantrine and pyronaridine-artesunate for uncomplicated Plasmodium falciparum malaria in Niger
Efficacy and tolerability of artemether–lumefantrine and pyronaridine-artesunate for uncomplicated Plasmodium falciparum malaria in Niger
Abstract
Background
Following the WHO recommendation for the use of Artemisinin based combination for treatment of uncomplicate...
Prevalence of substandard quality artemether-lumefantrine antimalarial agents in Uganda
Prevalence of substandard quality artemether-lumefantrine antimalarial agents in Uganda
Abstract
Background: Substandard antimalarial agents are a key challenge to effective malaria control and elimination efforts especially in sub-Saharan Africa. The quality ...
Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia
Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia
Abstract
Background
Cambodia has seen a marked reduction in the incidence of Plasmodium falciparum over the past decade without a corresponding decl...
Musta mere ranniku eesti asunikud malaaria meelevallas
Musta mere ranniku eesti asunikud malaaria meelevallas
At the end of the 19th century, Estonian settlers encountered malaria in the Volga region and Siberia, but outbreaks with the most serious consequences hit Estonians in the Black S...
Safety and therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at Shecha health centre, Arba Minch, Ethiopia
Safety and therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at Shecha health centre, Arba Minch, Ethiopia
Abstract
Background
In 2004, Ethiopia adopted artemether-lumefantrine (AL, Coartem®) as first-line treatment for the management of uncomplicated Pla...

